Microsoft: Fiscal Q4 Earnings Consensus Estimates

Microsoft (NASDAQ: MSFT) will be reporting their fiscal fourth quarter financials on July 27 after markets close. Analysts have a consensus $306.13 12-month price target on the company, via a total of 40 analysts, with 18 analysts having strong buy ratings. 20 analysts meanwhile have buy ratings and two have hold ratings. The street high sits at a $378 price target, and the lowest target sits at $256.70.

23 analysts have revenue estimates for the fourth quarter. The mean revenue estimate between all 23 analysts is $44.243 billion; this number has been revised upwards from $41.9 billion at the start of the year. The highest revenue estimate is $44.869 billion, while the lowest is $43.629 billion.

Onto EBITDA estimates, there are currently only 5 analysts who have fourth-quarter EBITDA estimates. The mean is currently $20.747 billion, with this number having been revised up from $18.474 billion at the start of the year. Street high is $20.915 billion EBITDA estimate and the lowest is $20.229 billion.

Analysts estimate that quarterly earnings per share will come in at $1.92, with this number being revised upwards from $1.71 at the start of the year. Street high is $2.03 and the lowest estimate is $1.81 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Higher Gold Prices Are Changing What Counts as a Real Discovery | Mike Bennett – Altamira Gold

Why Silver Still Hasn’t Seen the Real Mania | Craig Hemke

Why Copper Needs a Much Higher Price to Fix the Supply Problem | Greg Ferron – PTX Metals

Recommended

First Phosphate Lifts Bégin-Lamarche Indicated Tonnage by 378% In Latest Resource Update

Higher Gold Prices Are Changing What Counts as a Real Discovery | Mike Bennett – Altamira Gold

Related News

Canaccord Slashes Antibe Therapeutics Price Target A Month After Drug Trial Paused

On August 3, Antibe Therapeutics Inc. (TSX: ATE) announced that they have paused their study...

Wednesday, September 29, 2021, 11:44:00 AM

Target: Analyst Consensus First Quarter Estimates

Target Corporation (NYSE: TGT) will be reporting their first-quarter financial results May 19th before market...

Tuesday, May 18, 2021, 06:29:00 PM

Canaccord Maintains $1.00 Price Target On Tilt Holdings

TILT Holdings (CSE: TILT) reported its second quarter revenues recently, posting revenue that was down...

Wednesday, August 26, 2020, 11:27:00 AM

Xebec Adsorption: BMO Cuts Price Target To Just $0.85 After Poor Q2 Margins

Xebec Adsorption (TSX: XBC) yesterday announced its second quarter financial results. The company announced revenues...

Saturday, August 13, 2022, 03:04:00 PM

BMO Lifts Endeavour Silver’s Price Target Following Better Than Expected Q1 Results

On April 11th, Endeavour Silver Corp. (TSX: EDR) announced its first quarter of 2021 production...

Thursday, April 14, 2022, 11:24:00 AM